The purpose of this study is to see if a low-dose arm or a high dose-arm of immune tolerance
is more effective in eliminating inhibitors in patients with hemophilia A.
Phase:
N/A
Details
Lead Sponsor:
New York Presbyterian Hospital
Collaborators:
Central Manchester University Hospitals NHS Foundation Trust Manchester University NHS Foundation Trust